Published in Appl Environ Microbiol on February 01, 1977
Bacterial toxins: a table of lethal amounts. Microbiol Rev (1982) 3.74
Comparative genome and phenotypic analysis of Clostridium difficile 027 strains provides insight into the evolution of a hypervirulent bacterium. Genome Biol (2009) 3.66
Clostridium botulinum neurotoxin. Microbiol Rev (1980) 2.89
Purification and characterization of two components of botulinum C2 toxin. Infect Immun (1980) 2.74
Establishment of a monoclonal antibody recognizing an antigenic site common to Clostridium botulinum type B, C1, D, and E toxins and tetanus toxin. Infect Immun (1988) 1.74
Antigenic similarity of toxins produced by Clostridium botulinum type C and D strains. Infect Immun (1980) 1.56
Vascular permeability activity of botulinum C2 toxin elicited by cooperation of two dissimilar protein components. Infect Immun (1981) 1.38
Homogeneity and heterogeneity of toxins produced by Clostridium botulinum type C and D strains. Infect Immun (1981) 1.23
Four different monoclonal antibodies against type C1 toxin of Clostridium botulinum. Infect Immun (1982) 1.21
Binding of the two components of C2 toxin to epithelial cells and brush borders of mouse intestine. Infect Immun (1985) 1.15
Analysis of antigenicity of Clostridium botulinum type C1 and D toxins by polyclonal and monoclonal antibodies. Infect Immun (1984) 1.09
Purification and characterization of neurotoxin produced by Clostridium botulinum type C 6813. Infect Immun (1985) 0.96
Observations on toxin and hemagglutinin produced by Clostridium botulinum type C. Appl Environ Microbiol (1978) 0.94
Comparison of antigenicity of toxins produced by Clostridium botulinum type C and D strains. Appl Environ Microbiol (1984) 0.91
Molecular diversity of neurotoxins from Clostridium botulinum type D strains. Infect Immun (1989) 0.89
Purification and characterization of ADP-ribosyltransferases (exoenzyme C3) of Clostridium botulinum type C and D strains. J Bacteriol (1991) 0.86
Two different types of ADP-ribosyltransferase C3 from Clostridium botulinum type D lysogenized organisms. Infect Immun (1993) 0.81
Use of ganglioside affinity filters to identify toxigenic strains of Clostridium botulinum types C and D. Infect Immun (1979) 0.81
Cloning of the structural gene for Clostridium botulinum type C1 toxin and whole nucleotide sequence of its light chain component. Appl Environ Microbiol (1991) 0.79
Binding of Clostridium botulinum type C neurotoxin to different neuroblastoma cell lines. Infect Immun (1989) 0.75
Measurement of molecular weights by electrophoresis on SDS-acrylamide gel. Methods Enzymol (1972) 14.68
The Purification and Crystallization of Clostridium botulinum Type A Toxin. Science (1946) 12.77
Immunoaffinity chromatography of proteins. Methods Enzymol (1974) 6.40
A new method for the large-scale production of high-titre botulinum formol-toxoid types C and D. J Immunol (1950) 5.19
Rapid determination of molecular weights of peptides and preteins. Ann N Y Acad Sci (1960) 4.49
Statistical analysis of a rapid in vivo method for the titration of the toxin of Clostridium botulinum. J Bacteriol (1966) 3.91
Purification and some properties of Clostridium botulinum type-E toxin. Biochim Biophys Acta (1968) 2.87
A common subunit structure in Clostridium botulinum type A, B and E toxins. Biochem Biophys Res Commun (1972) 2.78
Chromatographic fractionation of the crystalline toxin of Clostridium botulinum type A. Biochem Biophys Res Commun (1966) 2.71
Isolation and sedimentation study of low molecular weight forms of type A Botulins toxin. Arch Biochem Biophys (1954) 2.34
Purification of Clostridium botuliunum type F progenitor toxin. Appl Microbiol (1974) 2.16
Separation of toxin and hemagglutinin from crystalline toxin of Clostridium botulinum type A by anion exchange chromatography and determination of their dimensions by gel filtration. J Biol Chem (1968) 2.02
Significance of 12S toxin of Clostridium botulinum type E. J Bacteriol (1969) 1.87
Isolation and characterization of Clostridium botulinum type B toxin. J Biol Chem (1969) 1.79
Isolation of chromatographically pure toxin of Clostridium botulinum type B. Biochem Biophys Res Commun (1968) 1.59
Molecular construction of Clostridium botulinum type F progenitor toxin. Appl Microbiol (1975) 1.48
Purification and properties of Clostridium botulinum type F toxin. Appl Microbiol (1975) 1.41
The role of sulfhydryl groups in the activity of type A botulinum toxin. Biochim Biophys Acta (1970) 1.33
Dissociation and reconstitution of 12-S toxin of Clostridium botulinum type E. Biochim Biophys Acta (1969) 1.23
Purification of Clostridium botulinum type A toxin. Biochim Biophys Acta (1970) 1.06
Purification and crystallization of Clostridium botulinum type C toxin. Jpn J Vet Res (1972) 0.93
BIBW2992, an irreversible EGFR/HER2 inhibitor highly effective in preclinical lung cancer models. Oncogene (2008) 6.82
Dilution is effective in reducing infusion phlebitis in peripheral parenteral nutrition: an experimental study in rabbits. Nutrition (1998) 1.96
Deletion of fcgamma receptor IIB renders H-2(b) mice susceptible to collagen-induced arthritis. J Exp Med (1999) 1.92
[Synthesis and bronchodilating activity of o-chloro-alpha-(tert-butylaminomethyl)-benzylalcohol hydrochloride (C-78) and related compounds (author's transl)]. Yakugaku Zasshi (1978) 1.87
Immunohistochemical and subcellular localization of Parkin protein: absence of protein in autosomal recessive juvenile parkinsonism patients. Ann Neurol (1999) 1.86
Establishment of a monoclonal antibody recognizing an antigenic site common to Clostridium botulinum type B, C1, D, and E toxins and tetanus toxin. Infect Immun (1988) 1.74
Preoperative portal vein embolization for hepatocellular carcinoma. World J Surg (1986) 1.72
Separation and characterization of heavy and light chains from Clostridium botulinum type C toxin and their reconstitution. J Biol Chem (1981) 1.58
Antigenic similarity of toxins produced by Clostridium botulinum type C and D strains. Infect Immun (1980) 1.56
Somatic mutation of mitochondrial DNA in cancerous and noncancerous liver tissue in individuals with hepatocellular carcinoma. Cancer Res (2001) 1.56
Assessment of transesophageal Doppler echography in dissecting aortic aneurysm. J Am Coll Cardiol (1989) 1.56
Epidermal cell differentiation inhibitor ADP-ribosylates small GTP-binding proteins and induces hyperplasia of epidermis. J Biol Chem (1992) 1.52
Influence of histological inflammatory activity on regenerative capacity of liver after percutaneous transhepatic portal vein embolization. J Gastroenterol (1999) 1.50
MuSK antibodies in AChR Ab-seropositive MG vs AChR Ab-seronegative MG. Neurology (2004) 1.40
Extension of surgical indications for hepatocellular carcinoma by portal vein embolization. World J Surg (1993) 1.40
Renal scarring is enhanced by phorbol myristate acetate following infection with bacteria with mannose-sensitive pili. Nephron (1993) 1.38
The complete nucleotide sequence of the gene coding for botulinum type C1 toxin in the C-ST phage genome. Biochem Biophys Res Commun (1990) 1.37
Preoperative portal vein embolization improves prognosis after right hepatectomy for hepatocellular carcinoma in patients with impaired hepatic function. Br J Surg (2000) 1.24
Homogeneity and heterogeneity of toxins produced by Clostridium botulinum type C and D strains. Infect Immun (1981) 1.23
Pharmacological studies of 1-(o-chlorophenyl)-2-tert.-butylaminoethanol (C-78), a new bonchodilator. Arzneimittelforschung (1975) 1.22
Pharmacological studies of o-chloro-alpha-[(tert.-butylamino)methyl]benzylalcohol hydrochloride (C-78), a new bronchodilator. II. Actions on the cardio-vascular system and smooth muscle organs. Arzneimittelforschung (1977) 1.21
Four different monoclonal antibodies against type C1 toxin of Clostridium botulinum. Infect Immun (1982) 1.21
Treatment of adrenal metastases after hepatic resection of a hepatocellular carcinoma. Dig Surg (2001) 1.17
Role of CD8beta domains in CD8 coreceptor function: importance for MHC I binding, signaling, and positive selection of CD8+ T cells in the thymus. Immunity (2000) 1.17
Submandibular sialoadenitis due to a foreign body. Br J Oral Maxillofac Surg (1990) 1.15
Florid cemento-osseous dysplasia. Radiographic study with special emphasis on computed tomography. Oral Surg Oral Med Oral Pathol (1994) 1.14
Analysis of antigenicity of Clostridium botulinum type C1 and D toxins by polyclonal and monoclonal antibodies. Infect Immun (1984) 1.09
Observation of long-distance radial correlation in toroidal plasma turbulence. Phys Rev Lett (2011) 1.08
Purification of a protective antigen from a saline extract of Pasteurella multocida. Infect Immun (1982) 1.08
Possible involvement of a small G-protein sensitive to exoenzyme C3 of Clostridium botulinum in the regulation of myofilament Ca2+ sensitivity in beta-escin skinned smooth muscle of guinea pig ileum. Jpn J Pharmacol (1995) 1.07
A new and simple method for the determination of thyroxine in serum. J Clin Endocrinol Metab (1966) 1.07
Clinicopathological factors predicting outcome after resection of mass-forming intrahepatic cholangiocarcinoma. Br J Surg (2001) 1.06
Determination of unbound warfarin enantiomers in human plasma and 7-hydroxywarfarin in human urine by chiral stationary-phase liquid chromatography with ultraviolet or fluorescence and on-line circular dichroism detection. J Chromatogr B Biomed Sci Appl (1997) 1.05
[A case report of autoimmune hepatitis with myasthenia gravis]. Nihon Shokakibyo Gakkai Zasshi (1988) 1.05
Nonsteroidal antiinflammatory agents. 2. Derivatives/analogues of dibenz[b,e]oxepin-3-acetic acid. J Med Chem (1978) 1.05
Molecular cloning and nucleotide sequencing of the Arthrobacter dextranase gene and its expression in Escherichia coli and Streptococcus sanguis. Jpn J Genet (1991) 1.04
The clinical significance of lymph node metastases in patients undergoing surgery for hepatocellular carcinoma. Surg Today (2000) 1.03
6,11-Dihydro-11-oxodibenz [b,e] oxepinacetic acids with potent antiinflammatory activity. J Med Chem (1976) 1.03
Pattern recognition as a caring partnership in families with cancer. J Adv Nurs (2000) 1.03
Complete rescue of lethal albino c14CoS mice by null mutation of 4-hydroxyphenylpyruvate dioxygenase and induction of apoptosis of hepatocytes in these mice by in vivo retrieval of the tyrosine catabolic pathway. J Biol Chem (1997) 1.02
The IL-2 receptor beta-chain (p70). Ligand binding ability of the cDNA-encoding membrane and secreted forms. J Immunol (1990) 1.02
Usefulness of positron emission tomography with fluorine-18-fluorodeoxyglucose for predicting outcome in patients with hepatocellular carcinoma. Am J Gastroenterol (2001) 1.01
Activation of Clostridium botulinum type E toxin purified by two different procedures. J Gen Microbiol (1986) 1.01
Grasping forceps assisted endoscopic resection of large pedunculated GI polypoid lesions. Gastrointest Endosc (1999) 1.01
Structure-activity relationship of endothelin: importance of charged groups. Biochem Biophys Res Commun (1989) 1.01
T cell receptor-mediated signaling events in CD4+CD8+ thymocytes undergoing thymic selection: requirement of calcineurin activation for thymic positive selection but not negative selection. J Exp Med (1995) 1.00
Effect of portal branch ligation on polyamine metabolism in rat liver. Life Sci (1986) 1.00
Novel antagonists for proteinase-activated receptor 2: inhibition of cellular and vascular responses in vitro and in vivo. Br J Pharmacol (2009) 1.00
Histologic factors affecting prognosis following hepatectomy for intrahepatic cholangiocarcinoma. World J Surg (2001) 0.99
Prognostic factors in patients surviving for more than 1 or 5 years after removal of metastatic brain tumors. Neurol Med Chir (Tokyo) (1992) 0.99
Production and characterization of serovar-specific monoclonal antibodies to serovars 4, 8, and 9 of Mycobacterium intracellulare. Infect Immun (1987) 0.99
Chemiluminescence of neutrophils from patients with Behçet's disease and its correlation with an increased proportion of uncommon serotypes of Streptococcus sanguis in the oral flora. Arch Oral Biol (1990) 0.98
Relationship of the microvascular type to the tumor size, arterialization and dedifferentiation of human hepatocellular carcinoma. Jpn J Cancer Res (2001) 0.98
[The drug sensitivity of enterohemorragic Escherichia coli and antibiotics treatment for hemorrhagic enterocolitis--from an outbreak of enterocolitis in Sakai city]. Jpn J Antibiot (1997) 0.97
Adenovirus as an integrating vector. Curr Gene Ther (2002) 0.97
Experimental infusion phlebitis: tolerance osmolality of peripheral venous endothelial cells. Nutrition (1998) 0.97
Phospholipid-sensitive Ca2+-dependent protein kinase system in testis: localization and endogenous substrates. Endocrinology (1984) 0.96
Molecular cloning of the gene encoding the mosaic neurotoxin, composed of parts of botulinum neurotoxin types C1 and D, and PCR detection of this gene from Clostridium botulinum type C organisms. Appl Environ Microbiol (1996) 0.96
Purification and characterization of neurotoxin produced by Clostridium botulinum type C 6813. Infect Immun (1985) 0.96
Oral administration of (-)catechin protects against ischemia-reperfusion-induced neuronal death in the gerbil. Free Radic Res (1998) 0.96
Urinary metabolites of gallic acid in rats and their radical-scavenging effects on 1,1-diphenyl-2-picrylhydrazyl radical. J Nat Prod (2000) 0.95
The intra-operative joint gap in cruciate-retaining compared with posterior-stabilised total knee replacement. J Bone Joint Surg Br (2009) 0.95
Identification of hBD-3 in respiratory tract and serum: the increase in pneumonia. Eur Respir J (2006) 0.95
Results of treatment of patients with hepatocellular carcinoma with severe cirrhosis of the liver. World J Surg (1989) 0.94
Perforated duodenal diverticulum: report of two cases. Hepatogastroenterology (1999) 0.94
Renal pelvic carcinoma producing granulocyte colony-stimulating factor: report of a case. Surg Today (2001) 0.94
Age-related change in the potential of bone marrow cells to repopulate the thymus and splenic T cells in mice. Cell Immunol (1986) 0.94
Age-associated changes in renal glomeruli of mice. Exp Gerontol (1989) 0.93
Accelerated tubular cell senescence in SMP30 knockout mice. Histol Histopathol (2006) 0.93
24th Bethesda conference: Cardiac transplantation. Task Force 5: Complications. J Am Coll Cardiol (1993) 0.93
Intrathymic T cell differentiation in radiation bone marrow chimeras and its role in T cell emigration to the spleen. An immunohistochemical study. J Immunol (1985) 0.93
Structure and toxicity of Clostridium botulinum type C toxin. Jpn J Med Sci Biol (1979) 0.93
Amount of enterotoxigenic Clostridium perfringens in meat detected by nested PCR. Int J Food Microbiol (1998) 0.93
Purification and crystallization of Clostridium botulinum type C toxin. Jpn J Vet Res (1972) 0.93
Influence of sodium, potassium, and pituitary hormones on iso-renin in rat adrenal glands. Am J Physiol (1974) 0.93
Familial Parkinson's disease. Alpha-synuclein and parkin. Adv Neurol (2001) 0.92
Changes and results of surgical strategies for hepatocellular carcinoma: results of a 15-year study on 452 consecutive patients. Surg Today (1998) 0.92
Tumor-suppressor effect of interferon regulatory factor-1 in human hepatocellular carcinoma. Clin Cancer Res (2001) 0.91
Comparison of antigenicity of toxins produced by Clostridium botulinum type C and D strains. Appl Environ Microbiol (1984) 0.91
Hemodynamic and renal effects of atrial natriuretic peptide in congestive heart failure. Am J Cardiol (1990) 0.91
Cytokeratin-19 fragments in serum (CYFRA 21-1) as a marker in primary liver cancer. Br J Cancer (2003) 0.91
Efficacy of major hepatic resection for large hepatocellular carcinoma. Hepatogastroenterology (1999) 0.90
Bifurcation, birooted primary canines: a case report. Int J Paediatr Dent (2001) 0.90
Effects of captopril on arterial and venous pressure, renal function, and humoral factors in severe chronic congestive heart failure. Clin Pharmacol Ther (1984) 0.90
Isolation and characterization of bovine haptoglobin from acute phase sera. J Biol Chem (1991) 0.90
Distribution of adenylate kinase isozymes in porcine tissues and their subcellular localization. J Biochem (1979) 0.90
ADP-ribosylation of specific membrane proteins in pheochromocytoma and primary-cultured brain cells by botulinum neurotoxins type C and D. FEBS Lett (1987) 0.90
Molecular diversity of neurotoxins from Clostridium botulinum type D strains. Infect Immun (1989) 0.89
Binding of Clostridium botulinum neurotoxin to gangliosides. J Biochem (1986) 0.89